- Home
- JAZZ vs NEU Comparison
JAZZ vs NEU Comparison
Compare JAZZ & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- NEU
- Stock Information
- Founded
- JAZZ 2003
- NEU 1887
- Country
- JAZZ Ireland
- NEU United States
- Employees
- JAZZ 2800
- NEU N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- NEU Major Chemicals
- Sector
- JAZZ Health Care
- NEU Industrials
- Exchange
- JAZZ Nasdaq
- NEU Nasdaq
- Market Cap
- JAZZ 7.0B
- NEU 6.7B
- IPO Year
- JAZZ 2007
- NEU N/A
- Fundamental
- Price
- JAZZ $108.94
- NEU $711.57
- Analyst Decision
- JAZZ Strong Buy
- NEU
- Analyst Count
- JAZZ 12
- NEU 0
- Target Price
- JAZZ $183.00
- NEU N/A
- AVG Volume (30 Days)
- JAZZ 628.2K
- NEU 71.3K
- Earning Date
- JAZZ 08-05-2025
- NEU 07-30-2025
- Dividend Yield
- JAZZ N/A
- NEU 1.55%
- EPS Growth
- JAZZ 49.21
- NEU 17.77
- EPS
- JAZZ 7.51
- NEU 50.47
- Revenue
- JAZZ $4,064,808,000.00
- NEU $2,779,049,000.00
- Revenue This Year
- JAZZ $6.10
- NEU N/A
- Revenue Next Year
- JAZZ $5.07
- NEU N/A
- P/E Ratio
- JAZZ $15.07
- NEU $13.99
- Revenue Growth
- JAZZ 5.76
- NEU 2.27
- 52 Week Low
- JAZZ $95.49
- NEU $480.00
- 52 Week High
- JAZZ $148.06
- NEU $743.52
- Technical
- Relative Strength Index (RSI)
- JAZZ 48.58
- NEU 53.35
- Support Level
- JAZZ $112.17
- NEU $643.60
- Resistance Level
- JAZZ $117.39
- NEU $742.88
- Average True Range (ATR)
- JAZZ 2.77
- NEU 14.79
- MACD
- JAZZ -0.33
- NEU -4.22
- Stochastic Oscillator
- JAZZ 24.15
- NEU 65.51
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About NEU NewMarket Corp
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.